Star Imaging and Path Lab shares will debut today on the BSE SME platform. Despite a strong IPO subscription of 5.67 times, the stock trades at a modest 4% grey market premium, hinting at muted listing gains. Investor focus remains on healthcare demand and diagnostics growth.